Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure.

ABSTRACT:

Background

We sought to examine whether factors impacting the time to emergency department (ED) administration of intravenous (IV) furosemide were associated with the duration of hospital admission for patients with acute heart failure (AHF).

Methods and results

We conducted a single-center, retrospective analysis of patients presenting to the ED and admitted between January 1, 2007 and December 31, 2014 who received a dose of IV furosemide. A Cox proportional hazards model was used to examine the likelihood that a patient would be discharged home alive, adjusting for patient demographics, AHF severity (low, moderate, high), laboratory result timing, and known AHF confounders. We identified 695 patients who met study criteria with 430 (61.9%) in the low-severity group. In th

SUBMITTER: Ward MJ 

PROVIDER: S-EPMC6141327 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature